Anxiolytics and psychotropic medications in central serous chorioretinopathy: Caveats and concerns

Indian J Ophthalmol. 2022 Feb;70(2):700-701. doi: 10.4103/ijo.IJO_2917_21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Anxiety Agents* / therapeutic use
  • Central Serous Chorioretinopathy* / diagnosis
  • Central Serous Chorioretinopathy* / drug therapy
  • Choroid Diseases*
  • Fluorescein Angiography
  • Humans

Substances

  • Anti-Anxiety Agents